CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −627 | $26.33 | $17K | 20,598 |
| 2026-08-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −2,716 | $32.01 | $87K | 21,370 |
| 2026-08-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −145 | $32.47 | $5K | 21,225 |
| 2026-08-14 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +6,000 | 24,086 | ||
| 2026-08-14 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Performance Stock Units | −6,000 | 0 | ||
| 2026-06-16 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −1,457 | $29.95 | $44K | 18,086 |
| 2026-03-20 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −8,692 | $33.64 | $292K | 20,144 |
| 2026-03-20 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −601 | $34.41 | $21K | 19,543 |
| 2026-03-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −4,222 | $31.28 | $132K | 29,242 |
| 2026-03-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −334 | $31.79 | $11K | 28,908 |
| 2026-03-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −72 | $32.85 | $2K | 28,836 |
| 2026-03-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −2,476 | $32.74 | $81K | 35,255 |
| 2026-03-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −1,791 | $33.38 | $60K | 33,464 |
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +7,475 | 19,731 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +6,000 | 25,731 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +12,000 | 37,731 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −7,475 | 7,475 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −6,000 | 12,000 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −12,000 | 36,000 | ||
| 2026-02-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Employee Stock Option (Right to Buy) | +53,000 | 53,000 |
Page 1 of 4 · 61 trades